An analysis of electronically monitored adherence to antiretroviral medications

AIDS and Behavior

Volumn 14, Issue 4, 2010, Pages 755-768

  Knafl, George J ^a   Bova, Carol A ^b   Fennie, Kristopher P ^c   O'Malley, Jean P ^d   Dieckhaus, Kevin D ^e   Williams, Ann B ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Adaptive statistical methods; Antiretroviral adherence; Electronic monitoring; MEMS caps

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ARTICLE; CLUSTER ANALYSIS; DRUG MONITORING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSTRUMENTATION; MALE; METHODOLOGY; MIDDLE AGED; MONITORING; PATIENT COMPLIANCE; POISSON DISTRIBUTION; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL MODEL; STATISTICS; VIROLOGY; VIRUS LOAD;

ANTIVIRAL AGENTS; CLUSTER ANALYSIS; DRUG MONITORING; FEMALE; HIV INFECTIONS; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; POISSON DISTRIBUTION; ROC CURVE; VIRAL LOAD; YOUNG ADULT;

EID: 77956884675     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-008-9512-z     Document Type: Article

References (26)

1. Ahn, J., McCombs, J. S., Jung, C., Croudace, T. J., McDonnell, D., Ascher-Svanum, A., et al. (2008). Classifying patients by antipsychotic adherence patterns using latent class analysis: Characteristics of nonadherent groups in the California Medicaid Program. Value in Health, 11, 48-56.
2. Bangsberg, D. R. (2006). Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clinical Infectious Diseases, 43, 939-941. doi:10.1086/ 507526. (Pubitemid 44435526)
3. Bangsberg, D. R. (2008). Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. The Journal of Infectious Diseases, 197, S272-S278. doi:10.1086/533415. (Pubitemid 351717317)
4. Bova, C., Fennie, K. P., Dieckhaus, K., Knafl, G. J., Watrous, E., & Williams, A. B. (2005). Use of electronic monitoring devices to measure antiretroviral adherence: Practical considerations. AIDS and Behavior, 9, 103-110. doi:10.1007/s10461-005-1685-0. (Pubitemid 40562187)
5. Delucchi, K., Knafl, G., Haug, N., & Sorensen, J. (2006). Adaptive Poisson modeling of medication adherence among HIV-positive methadone patients. In 2006 proceedings of the American Statistical Association, section on statistics in epidemiology (pp. 2525-2527). Alexandria: American Statistical Association.
6. Fletcher, C. V., Testa, M. A., Brundage, R. C., Chesney, M. A., Haubrich, R., Acosta, E. P., et al. (2005). Four measures of antiretroviral medication adherence and virologic response in AIDS Clinical Trials Group Study 359. Journal of Acquired Immune Deficiency Syndromes, 40, 301-306. doi:10.1097/01. qai.0000180078.53321.6a.
7. Gardner, E. M., Sharma, S., Peng, G., Hullsiek, K. H., Burman, W. J., MacArthur, R. D., et al. (2008). Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS (London, England), 22, 75-82.
8. Gerbino, P. P., & Shoheiber, O. (2007). Adherence patterns among patients treated with fixed-dose combination versus separate antihypertensive agents. American Journal of Health-System Pharmacy, 64, 1279-1283. doi:10.2146/ajhp060434. (Pubitemid 47216196)
9. Holzemer, W. L., Bakken, S., Portillo, C. J., Grimes, R., Welch, J., Wantland, S., et al. (2006). Testing a nurse-tailored HIV medication adherence intervention. Nursing Research, 55, 189-197. doi:10.1097/00006199-200605000- 00005. (Pubitemid 44503666)
10. Knafl, G. J., Fennie, K. P., Bova, C., Dieckhaus, K., & Williams, A. B. (2004). Electronic monitoring device event modelling on an individual-subject basis using adaptive Poisson regression. Statistics in Medicine, 23, 783-801. doi:10.1002/sim.1624. (Pubitemid 38279513)
11. Knafl, G. J., Fennie, K. P., & O'Malley, J. P. (2006). Adaptive repeated measures modeling using likelihood cross-validation. In B. Bovaruchuk (Ed.), Proceedings second IASTED international conference on computational intelligence (pp. 422-427). Anaheim: ACTA Press.
12. Knafl, G. J., & Grey, M. (2007). Factor analysis model evaluation through likelihood cross-validation. Statistical Methods in Medical Research, 16, 77-102. doi:10.1177/0962280206070649. (Pubitemid 46656626)
13. Liu, H., Miller, L. G., Hays, R. D., Golin, C. E., Wu, T., Wenger, N. S., et al. (2006). Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. Journal of Acquired Immune Deficiency Syndromes, 41, 315-322. doi: 10.1097/01.qai.0000197071.77482.6e.
14. Low-Beer, S., Yip, B., O'Shaughnessy, M. V., Hogg, R. S., & Montaner, J. S. G. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndromes, 23, 360-361.
15. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
16. Podsadecki, T. J., Vrijens, B. C., Tousset, E. P., Rode, R. A., & Hanna, G. J. (2007). Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia. The Journal of Infectious Diseases, 196, 1773-1778. doi:10.1086/523704. (Pubitemid 351411937)
17. Royston, P., & Altman, D. G. (1994). Regression using fractional polynomials of continuous covariates: Parsimonious parametric modelling. Applied Statistics, 43, 429-467. doi:10.2307/2986270.
18. Russell, C. L., Conn, V. S., Ashbaugh, C., Madsen, R., Hayes, K., & Ross, G. (2006). Medication adherence patterns in adult renal transplant recipients. Research in Nursing and Health, 29, 521-532. doi:10.1002/nur.20149
19. SAS Institute, Inc. (2004). SAS/STAT 9.1 user's guide. Cary, NC: SAS Institute.
20. Sereika, S. M., & Dunbar-Jacob, J. (2001). Analysis of electronic event monitored adherence. In L. E. Burke & I. S. Ockene (Eds.), Compliance in healthcare and research (pp. 139-162). Armonk, NY: Futura Publishing.
21. Shuter, J. (2008). Forgiveness of non-adherence to HIV-1 antiretro-viral therapy. The Journal of Antimicrobial Chemotherapy, 61, 769-773. doi:10.1093/jac/dkn020. (Pubitemid 351426058)
22. Shuter, J., Salro, J. A., Kanmaz, T. J., Rode, R. A., & Zingman, B. S. (2007). HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. Journal of Acquired Immune Deficiency Syndromes, 45, 4-8. doi:10.1097/QAI.0b013 e318050d8c2.
23. Stone, M. (1977). An asymptotic equivalence of choice of model by cross-validation and Akaike's criterion. Journal of the Royal Statistical Society: Series B, 39, 44-47.
24. Symons, M. J. (1981). Clustering criteria and multivariate normal mixtures. Biometrics, 37, 35-43. doi:10.2307/2530520.
25. Vrijens, B., Goetghebeur, E., de Klerk, E., Rode, R., Mayer, S., & Urquhart, J. (2005). Modelling the association between adherence and viral load in HIV-infected patients. Statistics in Medicine, 24, 2719-2731. doi:10.1002/sim.2130. (Pubitemid 41300806)
26. Williams, A. B., Fennie, K. P., Bova, C. A., Burgess, J. D., Danvers, K. A., & Dieckhaus, K. D. (2006). Home visits to improve adherence to highly active antiretroviral therapy: A randomized clinical trial. Journal of Acquired Immune Deficiency Syndromes, 42, 314-321. doi:10.1097/01.qai.0000221681.60187. 88. (Pubitemid 44050009)